BCTX
Briacell Therapeutics
$3.55
−$0.03 (−0.84%)Jul 27, 2026
Key metrics
The numbers that frame BCTX today
- Market cap
- $30.88M
- P/E (TTM)
- -1.0
- EV / FCF
- -0.8
- ROIC
- -411.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $2.60
- 52wk High
- $14.68
Growth
Revenue and earnings trend for BCTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BCTX
Is Briacell Therapeutics a good buy?
No. Briacell Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Briacell Therapeutics is selling at a very high price.
What is the market capitalization of BCTX?
Briacell Therapeutics's market capitalization is $30.88M.
What is the P/E ratio for BCTX stock?
Briacell Therapeutics's current P/E ratio is -1.
What is the 52-week high for BCTX stock?
The 52-week high for Briacell Therapeutics is $14.68. The current close of $3.55 is 75.8% below that high.
What is the 52-week low for BCTX stock?
The 52-week low for Briacell Therapeutics is $2.60. The current close of $3.55 is 36.5% above that low.
Does BCTX stock pay dividends?
Briacell Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BCTX?
Briacell Therapeutics's Debt / Equity ratio is 0.